Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3183)
All Articles published online
|
Aug 28, 2005 (publication date) through Jul 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Marra F, DeFranco R, Robino G, Novo E, Efsen E, Pastacaldi S, Zamara E, Vercelli A, Lottini B, Spirli C, Strazzabosco M, Pinzani M, Parola M. Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. World J Gastroenterol 2005; 11(32): 4931-4938 [PMID: 16124041 DOI: 10.3748/wjg.v11.i32.4931] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i32/4931.htm |
| Number | Citing Articles |
| 1 |
Jan F. Gerstenmaier, Dermot E. Malone. Mass lesions in chronic pancreatitis: benign or malignant? An “evidence-based practice” approach. Abdominal Imaging 2011; 36(5): 569 doi: 10.1007/s00261-010-9658-9
|
| 2 |
Chang Wang, Fei Peng, Bohua Zhong, Ying Shi, Xiaomei Wang, Xueyuan Jin, Junqi Niu. Metabolomic Analysis Reveals the Therapeutic Effects of MBT1805, a Novel Pan-Peroxisome Proliferator-Activated Receptor Agonist, on α-Naphthylisothiocyanate-Induced Cholestasis in Mice. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.732478
|
| 3 |
Shan Wang, Qing-Yun Zhang. Association of Lysosome associated protein transmembrane 4 beta gene polymorphism with the risk of pancreatic cancer. Chinese Journal of Cancer Research 2010; 22(4): 291 doi: 10.1007/s11670-010-0291-5
|
| 4 |
G Zhang, Y Liang, Y Huang, Y Chen, R Zhou. Elevated Lysosome-Associated Protein Transmembrane-4β-35 is an Independent Prognostic Marker in Pancreatic Carcinoma. Journal of International Medical Research 2012; 40(4): 1275 doi: 10.1177/147323001204000406
|
| 5 |
Benita L. McVicker, Robert G. Bennett. Novel Anti-fibrotic Therapies. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00318
|
| 6 |
Ester Gonzalez-Sanchez, Delphine Firrincieli, Chantal Housset, Nicolas Chignard. Nuclear Receptors in Acute and Chronic Cholestasis. Digestive Diseases 2015; 33(3): 357 doi: 10.1159/000371688
|
| 7 |
Robert G Bennett, Ronda L Simpson, Frederick G Hamel. Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis. World Journal of Gastroenterology 2017; 23(22): 3999-4006 doi: 10.3748/wjg.v23.i22.3999
|
| 8 |
Xin Guo, Xiaohui Lv, Cheng Fang, Xing Lv, Fengsong Wang, Dongmei Wang, Jun Zhao, Yueyun Ma, Yu Xue, Quan Bai, Xuebiao Yao, Yong Chen. Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling. International Journal of Cancer 2016; 139(8): 1821 doi: 10.1002/ijc.30227
|
| 9 |
Yi-Feng Zhou, Wei Xu, Xia Wang, Jin-Shan Sun, Jing-Jing Xiang, Zhao-Shen Li, Xiao-Feng Zhang. Negative methylation status of <italic>Vimentin</italic> predicts improved prognosis in pancreatic carcinoma. World Journal of Gastroenterology 2014; 20(36): 13172-13177 doi: 10.3748/wjg.v20.i36.13172
|
| 10 |
Ioana G. Lupescu, Mugur C. Grasu. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. 2022; : 99 doi: 10.1007/978-981-19-0063-1_13
|
| 11 |
Elisa Ceccherini, Antonella Cecchettini, Maria Aurora Morales, Silvia Rocchiccioli. The Potentiality of Herbal Remedies in Primary Sclerosing Cholangitis: From In Vitro to Clinical Studies. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00813
|